The Promise of Leadless Pacing: Based on Presentations at Nanostim Sponsored Symposium Held at the European Society of Cardiology Congress 2013, Amsterdam, The Netherlands, 2 September 2013
Key result
The Nanostim leadless pacemaker was successfully implanted in 97% of patients, demonstrating the feasibility of percutaneous leadless right ventricular cardiac pacing.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Feasibility of leadless RV pacing shown in early data; hypothesis-generating and should not yet change practice.
Study Design
Type
Observational (n=33)
Multicenter
Yes
Structured PICO
P
Population
33 patients (mean age 75, 36% female) requiring single-chamber ventricular pacing who underwent implantation of a novel leadless pacemaker.
I
Intervention
Leadless pacemaker
A completely self-contained leadless pacemaker shows promise in bypassing complications associated with traditional pacemaker leads and surgical pockets, based on early animal and human trials.
Limitations
- Relatively small feasibility study
- Currently only capable of single-chamber pacing
- No data on retrieval after long-term treatment
- Potential for learning curve complications
Cite This Study
Mountfort et al. (2014) conducted an observational in Cardiac arrhythmias requiring VVIR pacing (n=33). Nanostim Leadless Pacemaker was evaluated on Implantation success. The Nanostim leadless pacemaker was successfully implanted in 97% of patients, demonstrating the feasibility of percutaneous leadless right ventricular cardiac pacing.